First Report of Crown and Root Rot Caused by Pythium aphanidermatum on Industrial Hemp (Cannabis sativa) in Arizona

Spread the love

During July and August 2020, symptoms of leaf yellowing and browning, sudden wilting, and death were observed on industrial hemp plants (Cannabis sativa L.) in several drip-irrigated fields in Yuma and Graham county, Arizona. About 85% of plants showed severe crown and root rot symptoms. A high percentage of affected plants collapsed under intensive heat stress. Shriveled stem tissue with necrotic lesions can often be seen at the base of the plant, extending upwards more than 5 cm. Internal tissue of main stem and branches was darkened or pinkish brown. Outer cortex of root bark was often completely rotten, exposing the white core. Cottony aerial mycelium was visible on the surface of stalk of some of the infected plants in two fields in Yuma. To identify the causal agent, a total of twenty symptomatic plants were collected from several fields across the state. Crown and root tissues from affected plants were harvested and rinsed in tap water to remove soils. Approximately 2 to 4 mm tissue fragments were excised from the margins of the affected stem and root lesions, surface sterilized in 0.6% sodium hypochlorite for 1 min, rinsed copiously in sterile distilled water, blotted dry, and plated on potato dextrose agar (PDA), and on oomycete-selective clarified V8 medium containing pimaricin, ampicillin, rifampicin, and pentachloronitrobenzene (PARP). Plates were incubated at room temperature for 2 days. Sixteen isolates were recovered and their mycelial colonies resembled the morphology of Pythium. Based on the culture morphology on V8 medium, all isolates were tentatively identified as P. aphanidermatum with fast-growing, aseptate hyphae ranging from 3 to 7 μm in width, globose oogonia ranging from 25 to 31 μm in diameter, barrel-shaped antheridia, globose oospores ranging from 15 to 21 μm in diameter (10 measurements) (Watanabe, 2002). Genomic DNA was extracted from mycelial mats of three isolates using DNeasy Plant Pro Kit (Qiagen Inc., Valencia, CA) according to the manufacturer’s instructions. The internal transcribed spacer (ITS) region of rDNA was amplified with primers ITS1/ITS4 and three nucleotide sequences were obtained. All three sequences were identical and deposited under accession number MW380253 in GenBank. A BLASTn search revealed that MW380253 had a 100% query coverage and 100% match with sequences MK611609.1, KJ162355.1, and AY598622.2, obtained from isolates of P. aphanidermatum. To fulfill Koch’s postulates, pathogenicity tests were conducted with 2 isolates using 12 seeds of a hemp line 14 sown in 12 1.9-liter pots filled with a steam-disinfested potting mix. Pots were placed in a plastic container and watered three times a week by flooding, to create waterlogged conditions. Plants were maintained in a greenhouse supplemented with artificial lighting of 14 h/10 h day/night light cycle. Plants were fertilized weekly with a 20-20-20 fertilizer at 1mg/ml. Three weeks after sowing, four plants were inoculated with each isolate by drenching each plant with 200 ml of a 1×105 zoospore/ml suspension. Four plants, serving as control, received each 200 ml of distilled water. Symptoms of leaf chlorosis, crown and root rot, and wilting were observed 3 weeks afterwards, while control plants remained asymptomatic. P. aphanidermatum were re-isolated from necrotic roots of inoculated plants, but not from control plants. P. aphanidermatum was previously detected on industrial hemp in a research plot in Indiana (Beckerman et al., 2017) and is also known to affect other crops in Arizona during the summer months as well (Olsen & Nischwitz, 2011). This report is the first publication documenting P. aphanidermatum on field grown hemp in Arizona. Industrial hemp (Cannabis sativa) is an emerging crop in Arizona. The first plantings of hemp were in June of 2019, where 5,430 acres of hemp was planted in thirteen counties in Arizona before the end of the year. The Arizona Department of Agriculture Industrial Hemp Program, 2019 Year End Report confirms that nearly one-quarter of all hemp planted in 2019 did not receive a final state inspection due to crop loss. This disease is a potential constraint to hemp production in hot, arid climates, where copious water is used in combination with plastic mulch and/or drainage is poor.

Keywords: Cannabidiol; Damping off; Seedling disease; waterlogging.

Schaka

Related Posts

Phytocannabinoids – An Overview of the Analytical Methodologies for Detection and Quantification of Therapeutically and Recreationally Relevant Cannabis Compounds

Novel approaches in schizophrenia-from risk factors and hypotheses to novel drug targets

Rhode Island Delays Medical Cannabis Dispensary Licensing Lottery

Buckeye Duo Formally Files Adult-Use Cannabis Bill in Ohio

Signez la pétition !!!

 

845 signatures

Pétition ASBL Cannabis Belgique

Pourquoi une pétition ?

Nous sommes des personnes qui en avons assez de devoir aller dans la rue et avoir affaire à des réseaux criminels sans savoir où cela va nous conduire par après.

Nous sommes des personnes ayant des maladies, qui pour certaines sont rares, et utilisant pour médication le cannabis sous diverses formes (CBD,THC,THCv,CBDa,,,) sous l'accord de notre médecin.

Nous sommes des personnes responsables et honnêtes qui avons une vie épanouie et sans problèmes de vie ou sociaux.

Nous avons également une passion pour la plante de cannabis en elle-même et la cultiver est notre bonheur. De plus, nous pouvons nous soigner avec notre médication sans avoir peur des produits ou autres additifs contenus dans une plante que l'on peut trouver autre part.

Nous souhaitons pouvoir avoir notre médicament dans les normes de la santé publique, car un cannabis sain aide à réduire les frais de santé parfois conséquents pour la collectivité et le malade lui-même.

Nous sommes également des personnes responsables avec un rôle dans la société qui en avons assez d’être considérés comme des « hippies ou autres drogués », nous avons juste choisi notre médication et celle-ci a apporté les preuves de son efficacité dans le monde.

Nous connaissons déjà les produits dérivés comme le CBD et le THC que nous maîtrisons pour nous aider dans notre maladie « Je précise que nous ne sommes pas médecin et que nous nous basons sur 20 ans d’expérience médicale du cannabis des membres de notre ASBL et l'avis du médecin de famille ».

Nous désirons simplement ne plus nous cacher, et pouvoir aider les autres personnes le souhaitant.

Nous somme soucieux des ados et de la prévention à leur égard. Effectivement, nous sommes les acteurs parfaits pour répondre aux questions qu’ils se posent vu notre expérience cannabique et, de plus, nous pourrons leur expliquer les risques qu’ils encourent en achetant du cannabis dans la rue.

Le projet complet peut être demandé via mail " info@mcb.care " et sur le site internet : " http://mcb.care "

@ASBL McB

**votre signature**

Partagez avec vos amis

Articles récents

Catégories